XML 50 R28.htm IDEA: XBRL DOCUMENT
v3.25.2

SEGMENTED INFORMATION | 12 Months Ended
--- | ---
Mar. 31, 2025
Disclosure of operating segments [abstract] |
SEGMENTED INFORMATION [Text Block] | 23. SEGMENTED INFORMATION The Company's operating segments are organized into the following reportable segments: - Intellectual Property Development - Includes manufacturing and distribution of graphene related products. - Biotech - Includes service revenue generated through aptamer technology. - Albany Project - Includes the exploration and evaluation asset and mineral exploration activities. - Unallocated Corporate Costs - Includes corporate activities and certain unallocated costs. Performance of each reportable segment is measured based on profit before finance costs and income tax, as included in the internal management reports that are reviewed by the Company's Chief Operating Decision Makers, being the Board of Directors and senior leadership team. Segment profit (loss) is used to measure performance as management believes that such information is the most relevant in evaluating the results of certain segments relative to other entities that operate within these industries. Transfer pricing is based on third- party rates. Information regarding the results of each reportable segment is included below. Inter-company amounts, which represent items purchased and sold between different segments, have been presented within the segment disclosure and are eliminated to arrive at the consolidated amounts.
|  | IP Development |  |  | BioTech |  |  | Albany Project |  |  | Unallocated Corporate Costs |  |  | Total |
For the year ended March 31 |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
External net sales |  | 79,995 |  |  | 29,816 |  |  | 792,500 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 872,495 |  |  | 29,816 |
Cost of sales |  | 578,419 |  |  | 289,011 |  |  | 66,191 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 644,610 |  |  | 289,011 |
Depreciation and amortization |  | 600,322 |  |  | 613,714 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 600,322 |  |  | 613,714 |
Interest Expense |  | 91,323 |  |  | 107,373 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 91,323 |  |  | 107,373 |
Net loss |  | (7,075,798 | ) |  | (8,368,889 | ) |  | (262,462 | ) |  | (951,877 | ) |  | (18,597 | ) |  | (508,773 | ) |  | (2,682,801 | ) |  | (1,874,451 | ) |  | (10,039,658 | ) |  | (11,703,990 | )
Segment assets |  | 10,013,831 |  |  | 15,217,568 |  |  | 828,439 |  |  | 8,477 |  |  | 7,553,915 |  |  | 7,359,011 |  |  | - |  |  | - |  |  | 18,396,185 |  |  | 22,585,056 |
Segment liabilities |  | 2,816,136 |  |  | 2,199,276 |  |  | 238,003 |  |  | 145,833 |  |  | - |  |  | - |  |  | 592,599 |  |  | 66,736 |  |  | 3,646,738 |  |  | 2,411,845 |
Capital expenditures |  | 1,398 |  |  | 320,099 |  |  | - |  |  | - |  |  | 183,214 |  |  | 271,857 |  |  | - |  |  | - |  |  | 184,612 |  |  | 591,956 |

X
- Definition The entire disclosure for operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfOperatingSegmentsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration